© The Author 2006. Published by Oxford University Press.
ARTICLE |
The Response of CD24–/low/CD44+ Breast Cancer–Initiating Cells to Radiation
Affiliation of authors: Department of Radiation Oncology, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA
Correspondence to: Frank Pajonk, MD, PhD, Department of Radiation Oncology, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., Los Angeles, CA 90095-1714 (e-mail: fpajonk{at}mednet.ucla.edu).
Background: If cancer arises and is maintained by a small population of cancer-initiating cells within every tumor, understanding how these cells react to cancer treatment will facilitate improvement of cancer treatment in the future. Cancer-initiating cells can now be prospectively isolated from breast cancer cell lines and tumor samples and propagated as mammospheres in vitro under serum-free conditions. Methods: CD24–/low/CD44+ cancer-initiating cells were isolated from MCF-7 and MDA-MB-231 breast cancer monolayer cultures and propagated as mammospheres. Their response to radiation was investigated by assaying clonogenic survival and by measuring reactive oxygen species (ROS) levels, phosphorylation of the replacement histone H2AX, CD44 levels, CD24 levels, and Notch-1 activation using flow cytometry. All statistical tests were two-sided. Results: Cancer-initiating cells were more resistant to radiation than cells grown as monolayer cultures (MCF-7: monolayer cultures, mean surviving fraction at 2 Gy [SF2Gy] = 0.2, versus mammospheres, mean SF2Gy = 0.46, difference = 0.26, 95% confidence interval [CI] = 0.05 to 0.47; P = .026; MDA-MB-231: monolayer cultures, mean SF2Gy = 0.5, versus mammospheres, mean SF2Gy = 0.69, difference = 0.19, 95% CI = –0.07 to 0.45; P = .09). Levels of ROS increased in both mammospheres and monolayer cultures after irradiation with a single dose of 10 Gy but were lower in mammospheres than in monolayer cultures (MCF-7 monolayer cultures: 0 Gy, mean = 1.0, versus 10 Gy, mean = 3.32, difference = 2.32, 95% CI = 0.67 to 3.98; P = .026; mammospheres: 0 Gy, mean = 0.58, versus 10 Gy, mean = 1.46, difference = 0.88, 95% CI = 0.20 to 1.56; P = .031); phosphorylation of H2AX increased in irradiated monolayer cultures, but no change was observed in mammospheres. Fractionated doses of irradiation increased activation of Notch-1 (untreated, mean = 10.7, versus treated, mean = 15.1, difference = 4.4, 95% CI = 2.7 to 6.1, P = .002) and the percentage of the cancer stem/initiating cells in the nonadherent cell population of MCF-7 monolayer cultures (untreated, mean = 3.52%, versus treated, mean = 7.5%, difference = 3.98%, 95% CI = 1.67% to 6.25%, P = .009). Conclusions: Breast cancer–initiating cells are a relatively radioresistant subpopulation of breast cancer cells and increase in numbers after short courses of fractionated irradiation. These findings offer a possible mechanism for the accelerated repopulation of tumor cells observed during gaps in radiotherapy.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance
- Maximilian Diehn and Michael F. Clarke
J Natl Cancer Inst 2006 98: 1755-1757.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  V. Tirino, R. Camerlingo, R. Franco, D. Malanga, A. La Rocca, G. Viglietto, G. Rocco, and G. Pirozzi The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 446 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Short and D. T. Curiel Oncolytic adenoviruses targeted to cancer stem cells Mol. Cancer Ther., August 1, 2009; 8(8): 2096 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Y. Dane, C. Gottstein, and P. S. Daugherty Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypes Mol. Cancer Ther., May 1, 2009; 8(5): 1312 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Mani, K. W. Evans, B. G. Hollier, W. Guo, and R. A. Weinberg Generation of Stem-like Cells via EMT: A New Twist in Cancer Initiation and Progression Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 173 - 178. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Santisteban, J. M. Reiman, M. K. Asiedu, M. D. Behrens, A. Nassar, K. R. Kalli, P. Haluska, J. N. Ingle, L. C. Hartmann, M. H. Manjili, et al. Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells Cancer Res., April 1, 2009; 69(7): 2887 - 2895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Magnifico, L. Albano, S. Campaner, D. Delia, F. Castiglioni, P. Gasparini, G. Sozzi, E. Fontanella, S. Menard, and E. Tagliabue Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab Clin. Cancer Res., March 15, 2009; 15(6): 2010 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vlashi, K. Kim, C. Lagadec, L. D. Donna, J. T. McDonald, M. Eghbali, J. W. Sayre, E. Stefani, W. McBride, and F. Pajonk In Vivo Imaging, Tracking, and Targeting of Cancer Stem Cells J Natl Cancer Inst, March 4, 2009; 101(5): 350 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Deng, J. C. Liu, K. I. Pritchard, A. Eisen, and E. Zacksenhaus Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene Clin. Cancer Res., January 1, 2009; 15(1): 119 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Studebaker, G. Storci, J. L. Werbeck, P. Sansone, A. K. Sasser, S. Tavolari, T. Huang, M. W.Y. Chan, F. C. Marini, T. J. Rosol, et al. Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6-Dependent Manner Cancer Res., November 1, 2008; 68(21): 9087 - 9095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Tao, Y. Li, J. Zhou, J. Qian, R. L Schnaar, Y. Zhang, I. J Goldstein, H. Zhu, and J. P Schneck Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers Glycobiology, October 1, 2008; 18(10): 761 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-W. Chang, C. H. Lee, P. Lee, J. Lin, C.-W. Hsu, J.-T. Hung, J.-J. Lin, J.-C. Yu, L.-e. Shao, J. Yu, et al. Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis PNAS, August 19, 2008; 105(33): 11667 - 11672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lee, J. Dosch, and D. M. Simeone Pancreatic Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2806 - 2812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Winnard Jr., A. P. Pathak, S. Dhara, S. Y. Cho, V. Raman, and M. G. Pomper Molecular Imaging of Metastatic Potential J. Nucl. Med., June 1, 2008; 49(Suppl_2): 96S - 112S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, M. T. Lewis, J. Huang, C. Gutierrez, C. K. Osborne, M.-F. Wu, S. G. Hilsenbeck, A. Pavlick, X. Zhang, G. C. Chamness, et al. Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy J Natl Cancer Inst, May 7, 2008; 100(9): 672 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, R. Komaki, L. Wang, B. Fang, and J. Y. Chang Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus Clin. Cancer Res., May 1, 2008; 14(9): 2813 - 2823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Tang, B. T. Ang, and S. Pervaiz Cancer stem cell: target for anti-cancer therapy FASEB J, December 1, 2007; 21(14): 3777 - 3785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Brenner, I. Shuryak, S. Russo, and R. K. Sachs Reducing Second Breast Cancers: A Potential Role for Prophylactic Mammary Irradiation J. Clin. Oncol., November 1, 2007; 25(31): 4868 - 4872. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Hill and R. Perris "Destemming" Cancer Stem Cells J Natl Cancer Inst, October 3, 2007; 99(19): 1435 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Rich Cancer Stem Cells in Radiation Resistance Cancer Res., October 1, 2007; 67(19): 8980 - 8984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Farnie, R. B. Clarke, K. Spence, N. Pinnock, K. Brennan, N. G. Anderson, and N. J. Bundred Novel Cell Culture Technique for Primary Ductal Carcinoma In Situ: Role of Notch and Epidermal Growth Factor Receptor Signaling Pathways J Natl Cancer Inst, April 18, 2007; 99(8): 616 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Diehn and M. F. Clarke Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance J Natl Cancer Inst, December 20, 2006; 98(24): 1755 - 1757. [Full Text] [PDF]
|
|